Skip to main content
Loading

Opening Address & Keynote Presentation:

18 Sep 2025
Autologous Therapies in Solid Tumors and Beyond Allogeneic Access: Engineering the Future of Cell Therapy Cell Therapy Manufacturing: Automation, Assays & the Allo-Auto Divide Next Gen Vector Engineering & Delivery Gene Therapy CMC & Process Development Commercializing Gene Therapy in 2025